Table 1. AE's and SAE's recorded during the study.
| CT-Group | NO-Group | ||||
|---|---|---|---|---|---|
| N | (%) | N | (%) | P Value | |
| No. of Patient | 6 | 6 | |||
| No. of Patients with AE's | 2 | (33%) | 2 | (33%) | 1.000 |
| No. of Patients with SAE's | 1 | (16.66%) | 0 | (0%) | 1.000 |
| AE's associated with NO catheter | N/A | 0 | (0%) | ||
| SAE's associated with NO catheter | N/A | 0 | (0%) | ||
| AE's (Severity) | |||||
| Hematuria | 1 (Mild) | (16.66%) | 1 (Mild) | (16.66%) | 1.000 |
| Bleeding | 1 (Severe) | (16.66%) | 0 | (0%) | 1.000 |
| Hyperkalemia | 0 | (0%) | 1(Mild) | (16.66%) | 1.000 |
| SAE's | |||||
| Myocardial Infract | 1 | (16.66%) | 0 | (0%) | 1.000 |
Number and proportion of AE's and SAE's recorded during the study. Fisher's exact test was used for analyzing the difference in the number and the proportions of AE's and SAE's between both groups. p > 0.05, non-statistically significant difference. p < 0.05, statistically significant difference.